When we think of receding hairlines, we often picture men. But hairline recession affects millions of women worldwide, causing significant emotional distress and impacting self-confidence. Unlike the gradual temple recession commonly seen in men, women’s hairline loss can present differently and stem from various underlying causes.

Understanding why your hairline is receding is the first step toward finding an effective solution. This guide examines the most common causes of receding hairlines in women, the warning signs to watch for, and the treatment options available to slow, stop, or potentially reverse the process.


How Common Is Hairline Recession in Women?

While female pattern hair loss typically preserves the frontal hairline (causing diffuse thinning across the crown instead), many women do experience hairline recession. The patterns and prevalence vary depending on the underlying cause.

Research published in the Journal of Investigative Dermatology found that approximately 6% to 38% of healthy women experience some degree of frontal or frontal-parietal hair loss. The prevalence increases with age, rising from approximately 12% in women aged 20 to 29 years to over 50% of women over the age of 80.

Frontal fibrosing alopecia, a condition that specifically causes hairline recession in women, has seen a dramatic increase in diagnoses over the past two decades. A study from New York City estimated its prevalence at 0.015% among the general population, though researchers believe this figure may be higher due to underdiagnosis.


The Main Causes of Receding Hairlines in Women

1. Frontal Fibrosing Alopecia (FFA)

Frontal fibrosing alopecia is now the leading cause of scarring hairline recession in women. First described by Australian dermatologist Steven Kossard in 1994, this condition has become increasingly common worldwide over the past decade, though the reasons for this rise remain unclear.

What is it?

FFA is a form of scarring (cicatricial) alopecia that causes the immune system to attack hair follicles. This leads to inflammation that destroys the follicles’ stem cells. Once destroyed, the follicles cannot regenerate, making the hair loss permanent if not treated early.

Who does it affect?

FFA predominantly affects postmenopausal women, with 85% to 93% of cases occurring in this demographic. However, it can also affect premenopausal women and, rarely, men. The mean age of onset is typically between 55 and 65 years.

What does it look like?

The hallmark of FFA is a band of scarring hair loss along the frontal and temporal hairline. Women typically lose up to approximately eight centimetres of hair depth in this band. The affected skin appears pale, shiny, and atrophic (thinned). Characteristic features include:

  • Symmetrical recession of the frontotemporal hairline
  • Loss of eyebrows (occurring in 64% to 94% of cases, often affecting the outer portions first)
  • Isolated “lonely hairs” remaining within the scarred area
  • Possible loss of body hair including eyelashes, underarm, and pubic hair
  • Facial papules (small skin-coloured bumps) in some patients

What causes it?

The exact cause remains unknown. Research suggests a combination of factors:

  • Autoimmune mechanisms: The immune system attacks hair follicles, destroying the stem cells in the bulge region
  • Hormonal factors: The strong association with menopause suggests a potential hormonal component, though hormonal changes alone do not fully explain the condition
  • Genetic susceptibility: Family history and genome-wide association studies suggest genetic factors play a role
  • Environmental triggers: Some research has explored possible links to sunscreen ingredients or other topical products, though evidence remains inconclusive

2. Female Pattern Hair Loss with Temporal Recession

While female pattern hair loss (FPHL) classically causes diffuse thinning over the crown with preservation of the frontal hairline, some women do experience bitemporal recession similar to the pattern seen in men.

According to research published in Clinical, Cosmetic and Investigational Dermatology, three distinct patterns of female pattern hair loss exist:

  1. Ludwig pattern: Diffuse thinning of the crown with preservation of the frontal hairline (most common)
  2. Olsen pattern (Christmas tree): Triangular widening of the central part toward the front of the scalp
  3. Hamilton pattern: Bitemporal recession and vertex thinning resembling male pattern baldness (least common in women)

Studies suggest that women with Ludwig pattern hair loss may develop Hamilton pattern recession after menopause, indicating that hormonal changes can alter the presentation of hair loss over time.

The condition affects approximately 30 million women in the United States alone, according to the American Academy of Dermatology. Unlike FFA, female pattern hair loss is non-scarring, meaning follicles are miniaturised but not destroyed, making treatment more likely to produce regrowth.


3. Traction Alopecia

Traction alopecia is hair loss caused by repeated mechanical stress and tension on hair follicles. It commonly affects the hairline and temples because these areas bear the most strain from tight hairstyles.

Who is affected?

Traction alopecia can affect anyone who wears their hair in tight styles, but it is most prevalent among women of African descent due to cultural practices involving tight braiding, cornrows, weaves, and chemical or thermal hair treatments. A community-based study in Sudan found that 25% of women surveyed had traction alopecia, while a study in Cameroon documented a prevalence of 34.5% among women attending hair salons.

Although the condition is more common with tightly curled hair types, it also affects women who regularly wear tight ponytails, buns, hair extensions, or use heavy hair accessories.

What does it look like?

Traction alopecia typically presents as:

  • Hairline recession, particularly at the temples
  • Thinning along the “marginal” areas where hairstyles pull most tightly
  • Broken hairs of varying lengths in affected areas
  • Small bumps or pustules on the scalp (in early inflammatory stages)
  • Scalp tenderness or trichodynia (scalp pain)

Is it reversible?

Unlike FFA, early-stage traction alopecia is often reversible if the source of tension is eliminated. However, prolonged tension can lead to permanent scarring and irreversible follicle destruction.


4. Hormonal Causes

Several hormonal conditions can contribute to hairline recession in women:

Polycystic Ovary Syndrome (PCOS)

PCOS causes elevated androgen (male hormone) levels in women. These androgens can be converted to dihydrotestosterone (DHT), which shrinks hair follicles in a process called miniaturisation. Women with PCOS may experience hairline recession and overall thinning, sometimes following a male-pattern distribution.

Research indicates that PCOS is the most common endocrinological abnormality associated with female pattern hair loss. Characteristic features include irregular periods, acne, hirsutism (excess facial or body hair), and insulin resistance.

Thyroid Disorders

Both hypothyroidism (underactive thyroid) and hyperthyroidism (overactive thyroid) can disrupt the hair growth cycle. Thyroid hormones regulate the metabolic activity of hair follicles, and imbalances can push large numbers of follicles into the resting (telogen) phase prematurely, causing diffuse shedding.

Thyroid-related hair loss typically appears as generalised thinning rather than isolated hairline recession, but it can exacerbate existing hairline concerns or unmask underlying pattern hair loss.

Menopause

The hormonal shifts during menopause, particularly declining oestrogen and progesterone levels, can contribute to hair thinning and hairline changes. Oestrogen has a protective effect on hair, helping to keep follicles in the active growth phase. When oestrogen declines, the relative influence of androgens increases, which can trigger or worsen pattern hair loss.

Research published in Science Direct notes that progesterone inhibits the enzyme 5-alpha reductase, which converts testosterone to DHT. When progesterone levels fall during menopause, this inhibitory effect is reduced, potentially accelerating DHT-related hair loss.

Additionally, frontal fibrosing alopecia occurs almost exclusively in postmenopausal women, suggesting a complex relationship between menopause and hairline-specific hair loss.


5. Other Contributing Factors

Telogen Effluvium

Telogen effluvium is a form of temporary, diffuse hair shedding triggered by stress, illness, surgery, rapid weight loss, childbirth, or medication changes. While it typically causes generalised shedding rather than hairline recession, it can accentuate the appearance of an already vulnerable hairline.

The condition usually appears two to three months after the triggering event and often resolves within six to twelve months once the trigger is addressed.

Nutritional Deficiencies

Deficiencies in iron, vitamin D, vitamin B12, zinc, and protein can contribute to hair thinning and may worsen hairline recession. A 2019 review in Dermatology and Therapy confirmed that nutritional deficiencies are commonly found in women with hair loss and should be investigated and corrected as part of any treatment plan.

Autoimmune Conditions

Alopecia areata, an autoimmune condition causing patchy hair loss, can occasionally affect the hairline. Systemic lupus erythematosus and other autoimmune disorders can also present with hair loss that may include the frontal hairline.


Warning Signs of Hairline Recession

Recognising early signs of hairline recession allows for earlier intervention, which is particularly important in scarring conditions like frontal fibrosing alopecia where early treatment may prevent permanent loss.

Watch for:

  • Your hairline appearing higher than it used to be
  • Increased visibility of your forehead
  • Temples appearing thinner or more exposed
  • Baby hairs or fine vellus hairs replacing thicker terminal hairs at the hairline
  • Itching, burning, or tenderness along the hairline
  • Eyebrow thinning (especially the outer portions)
  • Broken hairs of varying lengths around the hairline
  • A pale, shiny, or scarred appearance of the skin at the hairline
  • Widening of the central parting extending toward the front

If you notice several of these signs, particularly if they are progressing, it is advisable to seek professional assessment sooner rather than later.


Diagnosing the Cause

Accurate diagnosis is essential because treatment approaches differ significantly depending on the underlying cause. A thorough assessment may include:

Clinical Examination

A trained practitioner will examine your scalp, hairline, and hair density. They will look for characteristic patterns, signs of scarring, inflammation, or follicular changes.

Trichoscopy (Dermoscopy)

This non-invasive technique uses magnification to examine the scalp and hair follicles in detail. It can reveal features suggestive of different conditions, such as perifollicular erythema (redness around follicles) in FFA or miniaturised hairs in pattern hair loss.

Blood Tests

Blood tests can identify hormonal imbalances, thyroid dysfunction, nutritional deficiencies, and other systemic factors contributing to hair loss. A comprehensive panel might include:

  • Thyroid function (TSH, free T3, free T4)
  • Iron studies (ferritin, serum iron, transferrin saturation)
  • Vitamin D
  • Vitamin B12
  • Full blood count
  • Hormones (testosterone, DHEA-S, SHBG, oestrogen, progesterone)
  • Prolactin
  • Fasting glucose and insulin (if PCOS is suspected)

Scalp Biopsy

In cases where the diagnosis is unclear, particularly to distinguish between scarring and non-scarring alopecias, a small scalp biopsy may be performed. Histopathological examination can confirm conditions like FFA or lichen planopilaris.


Treatment Options

Treatment depends entirely on the underlying cause of hairline recession. What works for one condition may be ineffective or inappropriate for another.

For Frontal Fibrosing Alopecia

FFA is challenging to treat, and there is currently no established consensus on the optimal approach. The primary goal is to halt progression, as regrowth in scarred areas is unlikely. Early intervention is crucial.

Medical treatments include:

  • Hydroxychloroquine: An immunomodulatory medication used as first-line treatment by many dermatologists
  • Intralesional corticosteroid injections: Injected into the active edge of hair loss to reduce inflammation
  • Oral finasteride or dutasteride: May help slow progression by reducing DHT
  • Topical or oral minoxidil: May support remaining hair but does not address the underlying inflammation
  • Immunosuppressants: Medications like mycophenolate mofetil or ciclosporin in severe cases

Because FFA is a scarring alopecia, hair regrowth in affected areas typically requires hair transplantation once the condition has stabilised. However, transplants carry risks of triggering further immune activity, so they must be approached carefully.


For Female Pattern Hair Loss

Non-scarring pattern hair loss responds better to treatment because follicles are miniaturised rather than destroyed.

Minoxidil

Topical minoxidil (2% or 5%) is the most widely used treatment for female pattern hair loss. It works by prolonging the anagen (growth) phase of the hair cycle and increasing blood flow to follicles. Oral low-dose minoxidil is also becoming more common for women who find topical application inconvenient or who experience scalp irritation.

A 2025 network meta-analysis found that among combination therapies for females with androgenetic alopecia, microneedling combined with minoxidil proved most effective (SUCRA = 87.18%).

Spironolactone

This anti-androgen medication can be prescribed for women with pattern hair loss, particularly those with signs of androgen excess. It blocks androgen receptors and reduces androgen production. It is not suitable for women who are or may become pregnant.

PRP (Platelet-Rich Plasma)

PRP therapy involves injecting concentrated platelets from your own blood into the scalp. The growth factors released by platelets stimulate hair follicle activity and may promote regrowth.

A meta-analysis of 13 studies comprising 435 patients found that PRP is more effective than 5% topical minoxidil for androgenetic alopecia. At Hair Loss Studios, we offer PRP as a treatment option for women with non-scarring hair loss affecting the hairline or crown.

Low-Level Light Therapy (LLLT)

LED devices and laser therapy can stimulate cellular activity in hair follicles. While results are modest, LLLT is a non-invasive option that can complement other treatments.


For Traction Alopecia

The most important treatment is eliminating the source of tension. This means:

  • Avoiding tight hairstyles such as braids, cornrows, tight ponytails, or buns
  • Limiting or eliminating chemical relaxers and heat styling
  • Choosing protective styles that do not pull on the hairline
  • Allowing the hair to rest without extensions or weaves for extended periods

If caught early, traction alopecia is often reversible. Medical treatments that may support recovery include:

  • Topical minoxidil: To stimulate regrowth in areas where follicles remain viable
  • PRP therapy: Growth factors may help strengthen weakened follicles
  • Topical or intralesional corticosteroids: To reduce inflammation if present

If permanent scarring has occurred, hair transplantation may be the only option for restoring density to the affected area.


For Hormonal Causes

Treating the underlying hormonal condition is essential:

  • PCOS: Management may include oral contraceptives, metformin (for insulin resistance), and anti-androgens such as spironolactone
  • Thyroid disorders: Levothyroxine for hypothyroidism or appropriate treatment for hyperthyroidism typically allows hair to recover over several months
  • Menopause: Hormone replacement therapy (HRT) may help, though the type of progestogen matters, as some synthetic progestogens have androgenic properties that could worsen hair loss

Once the hormonal imbalance is addressed, hair-specific treatments such as minoxidil or PRP may further support regrowth.


PRP for Hairline Recession

At Hair Loss Studios, PRP therapy is one of our core treatments for women experiencing hairline thinning. PRP delivers concentrated growth factors directly to the scalp, stimulating dormant follicles and creating a healthier environment for hair growth.

PRP may be appropriate for:

  • Female pattern hair loss with hairline involvement
  • Early-stage traction alopecia (before permanent scarring)
  • Supporting recovery after addressing hormonal imbalances
  • Complementing other treatments such as minoxidil

PRP is not suitable for advanced scarring conditions like FFA where follicles have been permanently destroyed. In such cases, we recommend referral to a dermatologist for specialist management before considering any adjunctive treatments.


Lifestyle and Supportive Measures

Regardless of the underlying cause, these measures can support overall hair health:

Nutrition

Ensure adequate intake of iron, zinc, vitamin D, B vitamins, protein, and omega-3 fatty acids. Consider blood tests to identify and correct any deficiencies.

Gentle Hair Care

Avoid harsh chemical treatments, excessive heat styling, and tight hairstyles. Use gentle, sulphate-free shampoos and wide-toothed combs.

Stress Management

Chronic stress can trigger or worsen telogen effluvium and may exacerbate other forms of hair loss. Techniques such as meditation, exercise, and adequate sleep can help.

Scalp Health

A healthy scalp environment supports healthy hair. Regular gentle cleansing, avoiding product buildup, and treating any scalp conditions (such as seborrhoeic dermatitis) can help.

Sun Protection

Some research has explored a possible link between sun exposure and frontal fibrosing alopecia, though the evidence remains inconclusive. Wearing hats or using non-irritating sun protection on exposed scalp areas may be prudent, particularly for those at risk of FFA.


When to Seek Professional Help

You should consider professional assessment if you notice:

  • Progressive hairline recession over weeks or months
  • Sudden or patchy hair loss
  • Scarring, redness, or inflammation along the hairline
  • Eyebrow thinning alongside hairline changes
  • Hair loss accompanied by other symptoms such as scalp pain, menstrual irregularities, fatigue, or weight changes
  • Hair loss that does not respond to over-the-counter treatments

Early intervention is particularly important for conditions like FFA, where delayed treatment may result in irreversible hair loss.


FAQs

Can a woman’s receding hairline grow back?

It depends on the cause. Non-scarring conditions like female pattern hair loss or early traction alopecia can respond well to treatment, with many women experiencing regrowth or improved density. Scarring conditions like frontal fibrosing alopecia destroy follicles permanently, so regrowth in scarred areas is not possible without hair transplantation once the disease has stabilised.

What is the most common cause of receding hairline in women?

Frontal fibrosing alopecia has become the most common cause of scarring hairline recession in women, particularly affecting postmenopausal women. For non-scarring hairline recession, traction alopecia (from tight hairstyles) and female pattern hair loss with temporal involvement are common causes.

Is frontal fibrosing alopecia the same as female pattern hair loss?

No. While both conditions can cause hair loss in women, they are distinct. Frontal fibrosing alopecia is a scarring (cicatricial) alopecia that permanently destroys hair follicles and specifically affects the hairline and often the eyebrows. Female pattern hair loss is non-scarring, typically causes diffuse thinning across the crown rather than hairline recession, and responds better to standard treatments.

Can tight hairstyles really cause permanent hair loss?

Yes. Prolonged tension from tight hairstyles can cause traction alopecia. In early stages, this is often reversible if the tension is removed. However, years of repeated pulling can lead to permanent scarring and irreversible follicle destruction. If you notice hairline recession, scalp tenderness, or broken hairs around your hairline, it is important to change your styling practices promptly.

Does menopause cause receding hairlines?

Menopause does not directly cause hairline recession, but the hormonal changes associated with menopause can trigger or worsen several conditions that affect the hairline. The decline in oestrogen and progesterone, combined with relatively increased androgen influence, can contribute to female pattern hair loss. Additionally, frontal fibrosing alopecia predominantly affects postmenopausal women, suggesting a hormonal link.

Can PRP help with a receding hairline?

PRP may help women with non-scarring hairline recession, such as female pattern hair loss with temporal involvement or early traction alopecia. Research shows that PRP can improve hair density and stimulate follicle activity. However, PRP cannot restore hair in areas where follicles have been permanently destroyed by scarring conditions like FFA.

Should I see a dermatologist for my receding hairline?

If you notice progressive hairline recession, particularly if accompanied by scalp changes (redness, scaling, or scarring), eyebrow thinning, or symptoms like tenderness or itching, you should see a dermatologist. Accurate diagnosis is essential because treatment differs significantly between conditions. Scarring alopecias like FFA require specialist management to prevent further permanent loss.

How quickly does frontal fibrosing alopecia progress?

FFA progression varies between individuals. Some women experience rapid recession over one to two years, while others have slow progression over many years. In some cases, the condition may stabilise spontaneously. Because the outcome is unpredictable and early treatment may prevent further permanent loss, prompt assessment is recommended.

Are there any new treatments for frontal fibrosing alopecia?

Research into FFA is ongoing. Current studies are exploring the efficacy of intralesional corticosteroids, JAK inhibitors, and other immunomodulatory therapies. A clinical trial investigating intralesional triamcinolone acetonide for FFA is underway in Spain. Because FFA is a relatively newly recognised condition with increasing incidence, more evidence-based treatment protocols are expected to emerge.

Can stress cause a receding hairline?

Stress typically causes telogen effluvium, which results in diffuse shedding rather than isolated hairline recession. However, stress-related shedding can make an already vulnerable hairline appear thinner. Chronic stress may also exacerbate underlying conditions. Addressing stress through lifestyle changes, therapy, or medical support is an important part of managing hair health.


Sources

  1. Birch MP, Messenger JF, Messenger AG. “Hair density, hair diameter and the prevalence of female pattern hair loss.” British Journal of Dermatology, 2001;144(2):297-304.
  2. Miao YJ, Jing J, Du XF, et al. “Frontal fibrosing alopecia: A review of disease pathogenesis.” Frontiers in Medicine, 2022;9:911944. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2022.911944/full
  3. Frontal Fibrosing Alopecia: A Comprehensive Review with Recent Updates. Indian Journal of Dermatology, Venereology and Leprology, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC11952711/
  4. Mayo Clinic. “Frontal fibrosing alopecia.” November 2025. https://www.mayoclinic.org/diseases-conditions/hair-loss/expert-answers/frontal-fibrosing-alopecia/faq-20485259
  5. Frontal Fibrosing Alopecia and Reproductive Health: Assessing the Role of Sex Hormones in Disease Development. International Journal of Molecular Sciences, 2024. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10817300/
  6. Alessandrini A, Starace M, Piraccini BM. “Female Pattern Hair Loss: Current treatment concepts.” Postgraduate Medicine, 2008;120(3):E01. https://pmc.ncbi.nlm.nih.gov/articles/PMC2684510/
  7. Lolli F, Pallotti F, Rossi A, et al. “Androgenetic alopecia: a review.” Endocrine, 2017;57(1):9-17.
  8. Redler S, Messenger AG, Betz RC. “Genetics and other factors in the aetiology of female pattern hair loss.” Experimental Dermatology, 2017;26(6):510-517.
  9. Traction Alopecia. StatPearls, NCBI Bookshelf. Updated May 2025. https://www.ncbi.nlm.nih.gov/books/NBK470434/
  10. Haskin A, Aguh C. “Traction alopecia: the root of the problem.” Clinical, Cosmetic and Investigational Dermatology, 2018;11:167-174. https://pmc.ncbi.nlm.nih.gov/articles/PMC5896661/
  11. Prevalence and Associated Factors of Traction Alopecia in Women in North Sudan. Medicina, 2025;61(2):195. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11857667/
  12. Gan DC, Sinclair RD. “Prevalence of male and female pattern hair loss in Maryborough.” Journal of Investigative Dermatology Symposium Proceedings, 2005;10(3):184-189.
  13. Relative efficacy of minoxidil in combination with other treatments for androgenic alopecia: a network meta-analysis. Frontiers in Pharmacology, 2025. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12483851/
  14. Menopause and hair loss in women: Exploring the hormonal transition. Maturitas, 2025. https://www.sciencedirect.com/science/article/pii/S0378512225001860
  15. Female Pattern Hair Loss. Dermnet, NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968982/
  16. Almohanna HM, Ahmed AA, Tsatalis JP, Tosti A. “The Role of Vitamins and Minerals in Hair Loss: A Review.” Dermatology and Therapy, 2019;9(1):51-70.

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Hairline recession in women can have multiple underlying causes, some of which require specialist dermatological assessment and treatment. Scarring conditions like frontal fibrosing alopecia should be evaluated by a dermatologist to prevent further permanent hair loss. If you are experiencing progressive hairline recession, we recommend seeking professional diagnosis before beginning any treatment. Hair Loss Studios offers professional hair restoration treatments for suitable candidates; readers should be aware of this commercial relationship when considering the information provided.